Myriad Genetics Inc
MYGN7.680USD
+0.280+3.78%
종가 09/18, 16:00（ET）시세는 15분 지연됩니다
715.01M시가총액
손실P/E TTM
자세한 내용은 Myriad Genetics Inc 회사
Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has specialized products, capabilities, and expertise: Oncology, Women's Health and Mental Health. In oncology, it offers testing for patients who have cancer and companion diagnostic tests that work with corresponding drugs and treatments. It also offers the SneakPeek Early Gender DNA Test which can reveal a baby's gender as early as six weeks into pregnancy. The Company’s testing products include MyRisk, BRACAnalysis, BRACAnalysis CDx, MyChoice CDx, Prolaris, Foresight, Prequel, Precis Tumor Test, Precise Liquid Test, SneakPeek and GeneSight, among others.
회사 정보
종목 코드 MYGN
회사 이름Myriad Genetics Inc
상장일Oct 06, 1995
CEOMr. Samraat S. (Sam) Raha
직원 수2700
유형Ordinary Share
회계 연도 종료Oct 06
주소322 North 2200 West
도시SALT LAKE CITY
증권 거래소NASDAQ Global Select Consolidated
국가United States of America
우편 번호84116
전화18015843600
웹사이트https://myriad.com/
종목 코드 MYGN
상장일Oct 06, 1995
CEOMr. Samraat S. (Sam) Raha
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Brian Donnelly
Mr. Brian Donnelly
Chief Commercial Officer
Chief Commercial Officer
397.53K
--
Mr. Mark S. Verratti
Mr. Mark S. Verratti
Chief Operating Officer and Chief Commercial Officer
Chief Operating Officer and Chief Commercial Officer
221.65K
-11.52%
Dr. Lee Nisley Newcomer, M.D.
Dr. Lee Nisley Newcomer, M.D.
Independent Director
Independent Director
132.14K
+60.47%
Ms. Margaret (Maggie) Ancona
Ms. Margaret (Maggie) Ancona
Senior Vice President, Chief of Staff
Senior Vice President, Chief of Staff
128.68K
+56.61%
Ms. Rashmi Kumar
Ms. Rashmi Kumar
Independent Director
Independent Director
127.19K
+64.34%
Ms. Shereen Solaiman
Ms. Shereen Solaiman
Chief People Officer
Chief People Officer
110.96K
+98.89%
Mr. Benjamin Richard (Ben) Wheeler
Mr. Benjamin Richard (Ben) Wheeler
Chief Financial Officer
Chief Financial Officer
95.21K
--
Dr. Dale Muzzey
Dr. Dale Muzzey
Chief Scientific Officer
Chief Scientific Officer
45.88K
-46.96%
Ms. S. Louise Phanstiel, CPA
Ms. S. Louise Phanstiel, CPA
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Matt Scalo
Mr. Matt Scalo
Investor Relations
Investor Relations
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Brian Donnelly
Mr. Brian Donnelly
Chief Commercial Officer
Chief Commercial Officer
397.53K
--
Mr. Mark S. Verratti
Mr. Mark S. Verratti
Chief Operating Officer and Chief Commercial Officer
Chief Operating Officer and Chief Commercial Officer
221.65K
-11.52%
Dr. Lee Nisley Newcomer, M.D.
Dr. Lee Nisley Newcomer, M.D.
Independent Director
Independent Director
132.14K
+60.47%
Ms. Margaret (Maggie) Ancona
Ms. Margaret (Maggie) Ancona
Senior Vice President, Chief of Staff
Senior Vice President, Chief of Staff
128.68K
+56.61%
Ms. Rashmi Kumar
Ms. Rashmi Kumar
Independent Director
Independent Director
127.19K
+64.34%
Ms. Shereen Solaiman
Ms. Shereen Solaiman
Chief People Officer
Chief People Officer
110.96K
+98.89%
수익 분석
통화: USD마지막 업데이트: Sun, Jul 6
통화: USD마지막 업데이트: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
사업별USD
이름
수익
비율
Hereditary Cancer
86.30M
44.05%
Prenatal
49.30M
25.17%
Pharmacogenomics
31.00M
15.82%
Tumor Profiling
29.30M
14.96%
지역별USD
이름
수익
비율
United States
181.60M
92.70%
Rest of world
14.30M
7.30%
사업별
지역별
사업별USD
이름
수익
비율
Hereditary Cancer
86.30M
44.05%
Prenatal
49.30M
25.17%
Pharmacogenomics
31.00M
15.82%
Tumor Profiling
29.30M
14.96%
주식 보유 통계
마지막 업데이트: Tue, Aug 19
마지막 업데이트: Tue, Aug 19
주주
주주 유형
주주
주주
비율
BlackRock Institutional Trust Company, N.A.
14.43%
The Vanguard Group, Inc.
9.83%
Millennium Management LLC
5.29%
State Street Global Advisors (US)
5.17%
Glenview Capital Management, LLC
4.93%
기타
60.34%
주주
주주
비율
BlackRock Institutional Trust Company, N.A.
14.43%
The Vanguard Group, Inc.
9.83%
Millennium Management LLC
5.29%
State Street Global Advisors (US)
5.17%
Glenview Capital Management, LLC
4.93%
기타
60.34%
주주 유형
주주
비율
Investment Advisor
37.35%
Hedge Fund
27.45%
Investment Advisor/Hedge Fund
24.82%
Research Firm
6.02%
Individual Investor
3.32%
Pension Fund
1.90%
Bank and Trust
0.41%
Venture Capital
0.31%
Family Office
0.08%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
518
100.80M
108.34%
-1.85M
2025Q1
527
99.14M
107.57%
-4.54M
2024Q4
516
96.89M
106.12%
-1.41M
2024Q3
505
95.02M
104.61%
-5.50M
2024Q2
486
96.79M
106.52%
-6.22M
2024Q1
460
98.19M
108.68%
+613.48K
2023Q4
464
93.46M
105.77%
+2.70M
2023Q3
471
86.01M
104.78%
-3.73M
2023Q2
480
84.60M
103.32%
-6.34M
2023Q1
483
85.87M
105.37%
-2.69M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
BlackRock Institutional Trust Company, N.A.
13.85M
15.02%
-471.44K
-3.29%
Mar 31, 2025
The Vanguard Group, Inc.
10.62M
11.52%
+47.03K
+0.44%
Mar 31, 2025
Millennium Management LLC
4.07M
4.41%
-275.67K
-6.34%
Mar 31, 2025
State Street Global Advisors (US)
5.27M
5.72%
-256.92K
-4.65%
Mar 31, 2025
Glenview Capital Management, LLC
3.90M
4.23%
-257.77K
-6.20%
Mar 31, 2025
D. E. Shaw & Co., L.P.
2.52M
2.74%
+702.80K
+38.62%
Mar 31, 2025
Morgan Stanley & Co. LLC
1.41M
1.52%
+434.87K
+44.81%
Mar 31, 2025
Geode Capital Management, L.L.C.
2.23M
2.42%
+87.90K
+4.10%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
2.21M
2.4%
-59.15K
-2.60%
Mar 31, 2025
Qube Research & Technologies Ltd
1.42M
1.54%
+416.78K
+41.62%
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Sep 6
마지막 업데이트: Sat, Sep 6
이름
비율
Invesco NASDAQ Future Gen 200 ETF
0.66%
WisdomTree BioRevolution Fund
0.45%
Invesco S&P SmallCap Health Care ETF
0.44%
Inspire Small/Mid Cap ESG ETF
0.24%
SPDR S&P Biotech ETF
0.18%
Vanguard US Quality Factor ETF
0.12%
Direxion Daily S&P Biotech Bull 3X Shares
0.1%
iShares S&P Small-Cap 600 Value ETF
0.09%
SPDR S&P 600 Small Cap Value ETF
0.09%
Invesco S&P SmallCap 600 Revenue ETF
0.07%
더 보기
Invesco NASDAQ Future Gen 200 ETF
비율0.66%
WisdomTree BioRevolution Fund
비율0.45%
Invesco S&P SmallCap Health Care ETF
비율0.44%
Inspire Small/Mid Cap ESG ETF
비율0.24%
SPDR S&P Biotech ETF
비율0.18%
Vanguard US Quality Factor ETF
비율0.12%
Direxion Daily S&P Biotech Bull 3X Shares
비율0.1%
iShares S&P Small-Cap 600 Value ETF
비율0.09%
SPDR S&P 600 Small Cap Value ETF
비율0.09%
Invesco S&P SmallCap 600 Revenue ETF
비율0.07%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
